1. Coronavirus Disease 2019 (COVID-19) Mitigation Efforts and Testing During an In-Person Training Event—Uganda, 12–29 October 2020
- Author
-
Aderonke Ajiboye, David Okimait, Kristin Brown, Rebecca L. Laws, Veronicah Mugisha, Carole Moore, Andrew C. Voetsch, Anna Awor, Dustin W Currie, Jennifer S. Galbraith, Andrea Low, Joshua Musinguzi, Lisa J. Nelson, Wilford Kirungi, Jennifer Ward, Karampreet Sachathep, Christina Mwangi, Wafaa El-Sadr, Mary Naluguza, Sam Biraro, Peter Nkurunziza, Hetal Patel, Wolfgang Hladik, Christine West, Brittany Gianetti, Sam Sendagala, David Hoos, Dorothy Aibo, Herbert Kiyingi, and Stephen Delgado
- Subjects
Microbiology (medical) ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,COVID-19 Vaccines ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,030231 tropical medicine ,Population ,Human immunodeficiency virus (HIV) ,medicine.disease_cause ,Asymptomatic ,mitigation ,03 medical and health sciences ,COVID-19 Testing ,0302 clinical medicine ,trainings ,Humans ,Medicine ,Uganda ,030212 general & internal medicine ,education ,education.field_of_study ,SARS-CoV-2 ,business.industry ,Transmission (medicine) ,COVID-19 ,virus diseases ,testing ,AcademicSubjects/MED00290 ,Infectious Diseases ,Family medicine ,Supplement Article ,medicine.symptom ,business - Abstract
Large public-health training events may result in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Universal SARS-CoV-2 testing during trainings for the Uganda Population-based HIV Impact Assessment identified 28 of 475 (5.9%) individuals with coronavirus disease 2019 (COVID-19) among attendees; most (89.3%) were asymptomatic. Until COVID-19 vaccine is readily available for staff and participants, effective COVID-19 mitigation measures, along with SARS-CoV-2 testing, are recommended for in-person trainings, particularly when trainees will have subsequent contact with survey participants.
- Published
- 2021
- Full Text
- View/download PDF